Gabelli Funds’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.08M | Buy |
8,550
+1,250
| +17% | +$165K | 0.01% | 906 |
|
|
2026
Q1 | $1.02M | Buy |
7,300
+1,000
| +16% | +$140K | 0.01% | 892 |
|
|
2025
Q4 | $773K | Buy |
6,300
+2,050
| +48% | +$249K | 0.01% | 971 |
|
|
2025
Q3 | $472K | Sell |
4,250
-225
| -5% | -$25.6K | ﹤0.01% | 1047 |
|
|
2025
Q2 | $496K | Sell |
4,475
-225
| -5% | -$23.9K | ﹤0.01% | 1017 |
|
|
2025
Q1 | $527K | Buy |
4,700
+515
| +12% | +$53.1K | ﹤0.01% | 895 |
|
|
2024
Q4 | $387K | Buy |
+4,185
| New | +$377K | ﹤0.01% | 934 |
|
|
2023
Q3 | – | Sell |
-26,271
| Closed | -$2.02M | – | 1146 |
|
|
2023
Q2 | $2.02M | Sell |
26,271
-2,300
| -8% | -$183K | 0.02% | 651 |
|
|
2023
Q1 | $2.37M | Hold |
28,571
| – | – | 0.02% | 632 |
|
|
2022
Q4 | $2.45M | Sell |
28,571
-4,250
| -13% | -$337K | 0.02% | 618 |
|
|
2022
Q3 | $2.02M | Sell |
32,821
-3,808
| -10% | -$240K | 0.02% | 650 |
|
|
2022
Q2 | $2.26M | Buy |
36,629
+2,300
| +7% | +$142K | 0.02% | 650 |
|
|
2022
Q1 | $2.04M | Sell |
34,329
-7,550
| -18% | -$483K | 0.01% | 712 |
|
|
2021
Q4 | $3.04M | Sell |
41,879
-14,500
| -26% | -$999K | 0.02% | 639 |
|
|
2021
Q3 | $3.94M | Buy |
56,379
+2,000
| +4% | +$141K | 0.03% | 570 |
|
|
2021
Q2 | $3.75M | Buy |
54,379
+1,300
| +2% | +$86.8K | 0.02% | 600 |
|
|
2021
Q1 | $3.43M | Sell |
53,079
-10,692
| -17% | -$689K | 0.02% | 603 |
|
|
2020
Q4 | $3.71M | Sell |
63,771
-34,500
| -35% | -$2.08M | 0.03% | 546 |
|
|
2020
Q3 | $6.21M | Sell |
98,271
-600
| -0.6% | -$41.6K | 0.05% | 396 |
|
|
2020
Q2 | $7.61M | Buy |
98,871
+9,000
| +10% | +$690K | 0.06% | 351 |
|
|
2020
Q1 | $6.72M | Buy |
89,871
+29,100
| +48% | +$2.01M | 0.06% | 359 |
|
|
2019
Q4 | $3.95M | Hold |
60,771
| – | – | 0.03% | 570 |
|
|
2019
Q3 | $3.85M | Hold |
60,771
| – | – | 0.03% | 580 |
|
|
2019
Q2 | $4.11M | Sell |
60,771
-4,272
| -7% | -$281K | 0.03% | 590 |
|
|
2019
Q1 | $4.23M | Hold |
65,043
| – | – | 0.03% | 581 |
|
|
2018
Q4 | $4.07M | Hold |
65,043
| – | – | 0.03% | 559 |
|
|
2018
Q3 | $5.02M | Hold |
65,043
| – | – | 0.03% | 570 |
|
|
2018
Q2 | $4.61M | Sell |
65,043
-6,000
| -8% | -$424K | 0.03% | 584 |
|
|
2018
Q1 | $5.36M | Sell |
71,043
-2,000
| -3% | -$159K | 0.03% | 540 |
|
|
2017
Q4 | $5.23M | Sell |
73,043
-68,457
| -48% | -$5.2M | 0.03% | 554 |
|
|
2017
Q3 | $11.5M | Buy |
141,500
+65,000
| +85% | +$4.97M | 0.07% | 362 |
|
|
2017
Q2 | $5.42M | Sell |
76,500
-10,000
| -12% | -$665K | 0.03% | 539 |
|
|
2017
Q1 | $5.88M | Buy |
86,500
+19,500
| +29% | +$1.37M | 0.03% | 521 |
|
|
2016
Q4 | $4.8M | Sell |
67,000
-30,000
| -31% | -$2.23M | 0.03% | 559 |
|
|
2016
Q3 | $7.67M | Sell |
97,000
-57,600
| -37% | -$4.68M | 0.05% | 441 |
|
|
2016
Q2 | $12.9M | Sell |
154,600
-36,200
| -19% | -$3.21M | 0.08% | 334 |
|
|
2016
Q1 | $17.5M | Buy |
190,800
+13,800
| +8% | +$1.24M | 0.11% | 266 |
|
|
2015
Q4 | $17.9M | Buy |
177,000
+10,000
| +6% | +$1.04M | 0.11% | 262 |
|
|
2015
Q3 | $16.4M | Buy |
167,000
+6,200
| +4% | +$689K | 0.1% | 283 |
|
|
2015
Q2 | $18.8M | Sell |
160,800
-64,000
| -28% | -$6.99M | 0.1% | 284 |
|
|
2015
Q1 | $22.1M | Buy |
224,800
+72,100
| +47% | +$7.32M | 0.11% | 261 |
|
|
2014
Q4 | $14.4M | Buy |
152,700
+2,600
| +2% | +$269K | 0.07% | 349 |
|
|
2014
Q3 | $16M | Sell |
150,100
-27,200
| -15% | -$2.66M | 0.08% | 327 |
|
|
2014
Q2 | $14.7M | Sell |
177,300
-12,000
| -6% | -$934K | 0.07% | 346 |
|
|
2014
Q1 | $13.4M | Buy |
189,300
+95,900
| +103% | +$7.52M | 0.07% | 354 |
|
|
2013
Q4 | $7.01M | Sell |
93,400
-27,900
| -23% | -$1.94M | 0.04% | 483 |
|
|
2013
Q3 | $7.63M | Buy |
121,300
+4,000
| +3% | +$239K | 0.04% | 463 |
|
|
2013
Q2 | $6.01M | Buy |
+117,300
| New | +$6.11M | 0.04% | 487 |
|
Other funds holding GILD
Gabelli Funds's GILD Position: Q2 2026 in Review
Gabelli Funds increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $165K and bringing the position to 8,550 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #906.
Gabelli Funds first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. The position peaked at $22.1M in Q1 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Gabelli Funds held 8,550 shares of Gilead Sciences worth $1.08M as of Q2 2026.
- Gabelli Funds bought 1,250 Gilead Sciences shares in Q2 2026, an estimated $165K.
- Gilead Sciences made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #906 holding.
- Gabelli Funds first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
- Gabelli Funds's Gilead Sciences position peaked at $22.1M in Q1 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.